Funds holding Bicara Therapeutics Inc
ISIN US0554771032 · United States
- Fund holders
- 159
- Of which ETFs
- 37 122 other funds
- Value held
- 270M $ 21.9M SEK
- Share of capital
- 20.9 % of 66.2M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 2,181,694 | 43.4M $ | 0.54 % | 3.30 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,371,353 | 27.3M $ | 0.00 % | 2.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 1,196,337 | 23.8M $ | 0.55 % | 1.81 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 944,900 | 15.9M $ | 0.30 % | 1.43 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 780,131 | 15.5M $ | 0.02 % | 1.18 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 705,031 | 14M $ | 0.15 % | 1.07 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 701,643 | 14M $ | 0.19 % | 1.06 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 642,514 | 12.8M $ | 0.12 % | 0.97 % | as of Mar 31, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 505,080 | 10.9M $ | 0.45 % | 0.76 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 387,402 | 8.4M $ | 0.81 % | 0.59 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 356,186 | 7.1M $ | 0.01 % | 0.54 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 311,681 | 6.7M $ | 0.02 % | 0.47 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 287,800 | 5.7M $ | 0.07 % | 0.43 % | as of Mar 31, 2026 ↗ |
| ClearBridge Small Cap Fund Legg Mason Global Asset Management Trust | 275,000 | 5.9M $ | 0.81 % | 0.42 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 253,669 | 5M $ | 0.04 % | 0.38 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 236,865 | 4.7M $ | 0.06 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 167,499 | 2.8M $ | 0.01 % | 0.25 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 156,105 | 2.6M $ | 0.02 % | 0.24 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 153,661 | 2.6M $ | 0.01 % | 0.23 % | as of Feb 28, 2026 ↗ |
| NORTH SQUARE DYNAMIC SMALL CAP FUND Exchange Place Advisors Trust | 140,170 | 2.4M $ | 0.34 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 130,808 | 2.6M $ | 0.06 % | 0.20 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 77,457 | 14.6M SEK | 0.46 % | 0.12 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 74,958 | 1.3M $ | 0.03 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 68,186 | 1.5M $ | 0.02 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 66,932 | 1.4M $ | 0.01 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 60,560 | 1M $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 57,294 | 961.4K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 52,448 | 1M $ | 0.02 % | 0.08 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 50,882 | 1M $ | 0.09 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 49,312 | 980.8K $ | 0.00 % | 0.07 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 48,826 | 819.3K $ | 0.59 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 46,771 | 930.3K $ | 0.16 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 46,030 | 772.4K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 45,205 | 899.1K $ | 0.06 % | 0.07 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 44,257 | 955.1K $ | 0.01 % | 0.07 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 42,187 | 839.1K $ | 0.05 % | 0.06 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 41,599 | 827.4K $ | 0.12 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 40,903 | 882.7K $ | 0.17 % | 0.06 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 38,945 | 7.3M SEK | 0.74 % | 0.06 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 38,300 | 761.8K $ | 0.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 36,790 | 731.8K $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 34,774 | 583.5K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 34,153 | 679.3K $ | 0.02 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 33,573 | 724.5K $ | 0.02 % | 0.05 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 32,196 | 694.8K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 30,587 | 608.4K $ | 0.07 % | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 27,746 | 465.6K $ | 0.02 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 25,842 | 433.6K $ | 0.03 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 24,800 | 493.3K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 24,723 | 414.9K $ | 0.02 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 24,554 | 412K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Optimize Strategy Index ETF Advisor Managed Portfolios | 23,996 | 477.3K $ | 0.23 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 22,700 | 451.5K $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 22,175 | 372.1K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 22,100 | 439.6K $ | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 21,657 | 430.8K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 21,580 | 429.2K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 21,580 | 362.1K $ | 0.03 % | 0.03 % | as of Feb 28, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 18,993 | 377.8K $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 18,169 | 304.9K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 17,159 | 370.3K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 17,135 | 340.8K $ | 0.15 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 15,977 | 344.8K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 14,934 | 322.3K $ | 0.86 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 14,729 | 293K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 13,680 | 295.2K $ | 0.02 % | 0.02 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 13,669 | 271.9K $ | 0.09 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 13,155 | 261.7K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 12,928 | 216.9K $ | 0.02 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 12,760 | 275.4K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 12,681 | 252.2K $ | 0.16 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 12,680 | 212.8K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 12,659 | 273.2K $ | 0.15 % | 0.02 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 12,551 | 249.6K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 11,218 | 242.1K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 11,200 | 222.8K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Company Value Trust John Hancock Variable Insurance Trust | 10,375 | 206.4K $ | 0.16 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 10,323 | 222.8K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 10,192 | 202.7K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 9,489 | 188.7K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 9,384 | 186.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 9,260 | 184.2K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 8,310 | 165.3K $ | 0.82 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 7,811 | 155.4K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 7,530 | 149.8K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 7,396 | 147.1K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 6,726 | 133.8K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 6,308 | 125.5K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 5,747 | 114.3K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 5,641 | 121.7K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 5,532 | 110K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 4,802 | 103.6K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 4,512 | 89.7K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 4,462 | 88.7K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 4,410 | 87.7K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 4,113 | 88.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 4,100 | 68.8K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 3,906 | 77.7K $ | 0.19 % | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 3,833 | 76.2K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 3,817 | 64K $ | 0.05 % | 0.01 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.86 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.82 % | as of Mar 31, 2026 ↗ |
| ClearBridge Small Cap Fund Legg Mason Global Asset Management Trust | 0.81 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.81 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 0.74 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.59 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 0.55 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 0.54 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 0.46 % | as of Mar 31, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 0.45 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 157 | +20 | 13,742,677 | +14.4 % |
| 2026Q1 | 137 | +15 | 12,008,304 | +50.8 % |
| 2025Q4 | 122 | +12 | 7,961,812 | +12.2 % |
| 2025Q3 | 110 | +3 | 7,094,624 | +23.6 % |
| 2025Q2 | 107 | +24 | 5,740,067 | +32.2 % |
| 2025Q1 | 83 | +60 | 4,342,499 | +128.2 % |
| 2024Q4 | 23 | 1,902,633 |
Institutional managers
141 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7,255,993 | 144.3M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 6,605,780 | 131.4K $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 5,802,970 | 115.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 5,425,000 | 107.9M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 4,062,500 | 80.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 3,339,218 | 66.4M $ | as of Mar 31, 2026 |
| RED TREE MANAGEMENT, LLC | 3,170,509 | 63.1M $ | as of Mar 31, 2026 |
| TPG GP A, LLC | 3,010,425 | 59.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,843,707 | 56.6M $ | as of Mar 31, 2026 |
| Omega Fund Management, LLC | 2,392,150 | 47.6M $ | as of Mar 31, 2026 |
| Royalty Pharma Sub-Manager, LLC | 2,388,150 | 46.7M $ | as of Mar 31, 2026 |
| FMR LLC | 2,100,929 | 41.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,659,342 | 33M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,621,643 | 32.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,419,388 | 28.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,376,198 | 27.4K $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 1,260,136 | 25.1M $ | as of Mar 31, 2026 |
| Atle Fund Management AB | 1,169,634 | 2.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 830,906 | 16.5M $ | as of Mar 31, 2026 |
| FIL Ltd | 679,904 | 13.5M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 667,300 | 13.3M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 643,382 | 12.8M $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 568,919 | 11.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 558,964 | 11.1M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 550,408 | 10.9M $ | as of Mar 31, 2026 |
Declared shareholders of Bicara Therapeutics Inc
There are 6 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.10 % | 6,605,780 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vestal Point Capital, LP and 1 other | 8.30 % | 5,425,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Deep Track Capital, LP and 2 others | 6.21 % | 4,062,500 | as of Mar 31, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 5.10 % | 3,339,218 | as of Mar 31, 2026 · SCHEDULE 13G |
| Red Tree GP, LLC and 2 others | 4.80 % | 3,170,509 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 3.20 % | 2,100,929 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Bicara Therapeutics Inc". https://titelia.com/en/stocks/bicara-therapeutics-inc-US0554771032